BMI, obesity

Researchers at the, Riverside, backed by a substantial NIH grant, are pioneering a study on the unique immune responses to ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...
Over-availability of food: Since cats do not need to hunt to eat when they are confined to the house, they sometimes eat just ...
A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a ...
Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients ...
The Lancet Commission has declared obesity a disease. With enough controversy to fill a buffet table, their new definition is ...